Prospective Recurrent Pregnancy Loss Registry
Launched by UNIVERSITY OF BRITISH COLUMBIA · Aug 3, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Prospective Recurrent Pregnancy Loss Registry is a study aimed at understanding and improving care for women who have experienced recurrent pregnancy loss, which means having two or more miscarriages or at least one miscarriage after 10 weeks of pregnancy. This research is being conducted at the BC Women's Hospital, where they will collect information over time to see how different treatments and investigations affect the health and outcomes of these patients.
To be eligible for this study, women must be new or returning patients at the BC Women's Recurrent Pregnancy Loss Clinic and have a history of recurrent pregnancy loss. However, if someone is seeking care for reasons unrelated to recurrent pregnancy loss, they would not be able to participate. Those who join the study can expect to share their experiences and medical history, which will help the researchers learn more about this condition and potentially improve future treatments for others facing similar challenges.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • • Patients seen at the BC Women's Recurrent Pregnancy Loss Clinic with recurrent pregnancy loss, defined as ≥2 pregnancy losses before 20 weeks of gestation.
- Exclusion Criteria:
- • • Patients at BC Women's Recurrent Pregnancy Loss Clinic seen for reasons other than recurrent pregnancy loss.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Mohamed A. Bedaiwy, MD, PhD
Principal Investigator
BC Women's Hospital & Health Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported